Fludarabine and mitoxantrone for the refractory relapse treatment of B-cell low-grade non-Hodgkin lymphoma (NHL):: LACOHG first interim report (Latin American Cooperative Oncology Hematology Group).

被引：0

作者：

Baltazar-Arellano, Severiano

Pimentel, Patricia

Vera, Luis

Bezares, Fernando

Malaga, Jose

Huamani-Z, Julia

Montante, Antonio

Rivas-Vera, Silvia

Carrasco-Yalan, Antonio A.

Beltran-Garate, Brady E.

机构：

[1] Ctr Med Noreste, Monterrey, Mexico

[2] Hosp Edgardo Rebagliati Martins, Dept Hematol Oncol, Lima, Peru

[3] Hosp Alvarez, Dept Hematol, Buenos Aires, DF, Argentina

[4] Hosp Natl Del Sur, Dept Hematol, Arequipa, Peru

[5] Hosp Gen Mexico OD, Mexico City, DF, Mexico

[6] Inst Nacl Cancerol, Mexico City, DF, Mexico

来源：

BLOOD | 2006年 / 108卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4665

引用

页码：247B / 248B

页数：2

共 50 条

[41] Temozolomide-induced aplastic anaemia and incidental low-grade B-cell non-Hodgkin lymphoma in a geriatric patient with glioblastoma multiforme
Batalini, Felipe
Kaufmann, Matthew R.
Aleixo, Gabriel Francisco
Drews, Reed
BMJ CASE REPORTS, 2019, 12 (06)
[42] A phase II study of mitoxantrone and fludarabine followed by anti-CD20 monoclonal in the treatment of patients with previously untreated low grade non-Hodgkin's lymphoma (LG-NHL).
Gregory, SA
Venugopal, P
Adler, SS
O'Brien, TM
O'Donnell, KF
Subramanian, A
Robin, EL
BLOOD, 2000, 96 (11) : 732A - 732A
[43] Randomized comparison of cladribine alone or in combination with cyclophosphamide, and cyclophosphamide, vincristine and prednisone in previously untreated low-grade B-cell non-Hodgkin lymphoma patients - Final report of the Polish Lymphoma Research Group
Kalinka-Warzocha, Ewa
Wajs, Jaroslaw
Lech-Maranda, Ewa
Ceglarek, Bernadetta
Holowiecki, Jerzy
Federowicz, Irena
Walewski, Jan
Czyz, Jaroslaw
Robak, Tadeusz
Warzocha, Krzysztof
CANCER, 2008, 113 (02) : 367 - 375
[44] Spontaneous remission of low-grade B-cell non-Hodgkin's lymphoma following withdrawal of methotrexate in a patient with rheumatoid arthritis: case report and review of the literature
Baird, RD
van Zyl-Smit, RN
Dilke, T
Scott, SE
Rassam, SMB
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (02) : 567 - 568
[45] High effectiveness of 2-CDA in B-cell leukemic low grade non-Hodgkin's lymphoma (NHL), but considerable risk for infection.
Knauf, WU
Hilgenfeld, E
Schutte, J
Kreuser, ED
Kath, R
Berdel, WE
Thiel, E
BLOOD, 1995, 86 (10) : 3333 - 3333
[46] Radioimmunotherapy with yttrium 90 ibritumomab tiuxetan (Zevalin®) is a safe and effective treatment option for older patients with relapsed or refractory low-grade non-Hodgkin's lymphoma (NHL)
Meredith, R
Schilder, RJ
Emmanouilides, C
Vo, K
Witzig, TE
Flinn, IW
Darif, M
Gordon, LI
Molina, A
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S421 - S421
[47] Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas
Vose, JM
Wahl, RL
Saleh, M
Rohatiner, AZ
Knox, SJ
Radford, JA
Zelenetz, AD
Tidmarsh, GF
Stagg, RJ
Kaminski, MS
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) : 1316 - 1323
[48] Outcome of children with B-cell non-Hodgkin's lymphoma: A report from Chinese multi-center cooperative group.
Tang, JY
Pan, C
Chen, J
Chen, HJ
Wu, Y
Wang, YP
BLOOD, 2001, 98 (11) : 235B - 235B
[49] Primary low-grade B cell non-Hodgkin's lymphoma of MALT type simultaneously arising in the colon and in the lung - Report of a case
Sallach, S
Schmidt, T
Pehl, C
Gallenberger, S
Keiditsch, E
Starostik, P
Ott, G
Schepp, W
DISEASES OF THE COLON & RECTUM, 2001, 44 (03) : 448 - 452
[50] Long-term results of the first Italian Association of Pediatric Hematology and Oncology Protocol for the Treatment of Pediatric B-Cell Non-Hodgkin Lymphoma (AIEOP LNH92)
Pillon, M
Di Tullio, MT
Garaventa, A
Cesaro, S
Putti, MC
Favre, C
Lippi, A
Surico, G
Di Cataldo, A
D'Amore, E
Zanesco, L
Rosolen, A
CANCER, 2004, 101 (02) : 385 - 394

← 1 2 3 4 5 →